SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma

24Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Cyclin D1 (CCND1) protein overexpression and/or the t(11;14)(q13;q32) translocation are the pathognomonic hallmarks of mantle cell lymphoma (MCL). However, there have been cases that lacked both t(11;14) and cyclin D1 protein but still had a gene expression profile suggesting a diagnosis of MCL. SOX11 expression was detected in most cyclin D1-negative MCL and can serve as a specific biomarker for the diagnosis of this subset of MCL. Lack of SOX11 expression in MCL was associated with an indolent subset and favorable prognosis.

Cite

CITATION STYLE

APA

Narurkar, R., Alkayem, M., & Liu, D. (2016). SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma. Biomarker Research. BioMed Central Ltd. https://doi.org/10.1186/s40364-016-0060-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free